Clarus Therapeutics Holdings Inc. (CRXT) Return on Investment ROI from the second quarter of 2022 to second quarter of 2021 and for the year 2022, average high and low, overall ranking from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Clarus Therapeutics Holdings Inc.  (NASDAQ: CRXT)


Clarus Therapeutics Holdings's ROI from its second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Clarus Therapeutics Holdings's ROI in the second quarter of 2022?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Clarus Therapeutics Holdings Inc.'s return on investment (ROI) in its second quarter of 2022

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -13 -29 -14 -19 -302
Return On Investment (TTM) - - - - -
CRXT's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -35 -43 -43 -36 -28

CRXT Company Profile >> Back to CRXT Roi Comparisons >> See Annual CRXT Return On Investment



Return On Investment CRXT's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Clarus Therapeutics Holdings's II. Quarter Investments $ -13 Millions CRXT's Balance sheet
Clarus Therapeutics Holdings's II. Quarter Income $ -11 Millions Quarterly CRXT's Income Statement
CRXT's Income by Division See CRXT's Income by Division


CRXT Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020


Total Investments in Millions -14 -37 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -40 4 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CRXT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CRXT's Competitors
Subscribers only: Roi for Clarus Therapeutics Holdings's Suppliers
Subscribers only: Return On Investment for CRXT's Customers

Other Ratios
CRXT's Roa CRXT's Inventory Turnover Ratio CRXT's Growth Rates CRXT's Dividend Statistics
CRXT's Profitability Ratios CRXT's Asset Turnover Ratio CRXT's Dividend Growth
CRXT's Roe CRXT's Valuation Ratios CRXT's Financial Strength Ratios CRXT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2022, within Healthcare Sector ROI
Briacell Therapeutics Corp   195.05 %
Moderna Inc   87.69 %
Talphera Inc   82.07 %
Sensus Healthcare Inc   73.30 %
Omeros Corporation  71.25 %
Molecular Templates Inc   65.54 %
Vir Biotechnology Inc   62.34 %
Vivos Therapeutics Inc   61.70 %
Iteos Therapeutics Inc   57.95 %
Biomx Inc  57.70 %
Oncotelic Therapeutics Inc   55.35 %
Vyne Therapeutics Inc   54.42 %
Effector Therapeutics Inc   50.94 %
REST EZ Inc.  48.50 %
Vicarious Surgical Inc  47.36 %
Journey Medical Corp  47.30 %
Siga Technologies Inc  46.20 %
Glucotrack Inc   45.65 %
Dynavax Technologies Corporation  44.50 %
Idexx Laboratories Inc  39.70 %
Avid Bioservices Inc   37.24 %

Date modified: 2026-09-26T07:40:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.